Strongbridge Biopharma
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Strongbridge Biopharma's past years’ income statements indicate that its last revenue has increased compared to the previous period by 42% to $30,731,000. The net income raised on -$45,075,000 and profit margin reached -147%. Total operating expenses were $71,684,000.

Profit Margin

Strongbridge Biopharma plc (NASDAQ:SBBP): Profit margin
2013 0 -5.29M
2014 0 -9.67M
2015 0 -43.58M
2016 0 -48.59M
2017 7.04M -113.48M -1610.6%
2018 18.02M 31.85M 176.68%
2019 21.71M -49.45M -227.76%
2020 30.73M -45.07M -146.68%

SBBP Income Statement (2013 – 2020)

2020 2019 2018 2017 2016 2015 2014 2013
Revenue
Revenue
30.73M21.71M18.02M7.04M0000
Cost of revenue
2.21M3.82M3.98M1.48M0000
Gross profit
28.51M17.89M14.04M5.56M0000
Operating exp.
Research and development
25.79M30.90M25.44M17.26M20.02M20.13M5.84M2.53M
Selling and marketing
00000000
Total operating expenses
71.68M81.73M95.96M58.58M34.89M42.85M10.43M-5.19M
Operating income
-43.16M-63.84M-81.92M-53.01M-34.89M-42.85M-10.43M-5.19M
Other income (expenses), net
-1.92M16.16M114.31M-58.69M-16.45M-1.22M282K-288K
Income before tax
-45.09M-47.68M32.38M-111.71M-51.35M-44.08M-10.15M-5.48M
Income tax expense
-15K1.76M536K1.77M-2.63M-450K-480K-93K
Net income
-45.07M-49.45M31.85M-113.48M-48.59M-43.58M-9.67M-5.29M
Earnings per share
Basic EPS
-0.8-0.890.64-3.11-2.26-2.62-0.96-0.88
Diluted EPS
-0.8-0.890.64-3.11-2.24-2.62-0.96-0.88
Data sourceData sourceData sourceData source